Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

SHBG may be a useful early indicator and treatment target for PCOS.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Some cats with sudden hair loss and tiredness might have cancer-related alopecia.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

A rare adrenal tumor in a 14-year-old girl caused male-like symptoms and was successfully removed.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Thyroxine can adjust the body's peripheral clock, potentially helping treat clock-related diseases.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.